HER2 as a Predictive Biomarker and Treatment Target in Colorectal Cancer
Astrid De Cuyper, Marc Van den Eynde, Jean‐Pascal Machiels
Topics & Concepts
PanitumumabCetuximabMedicineTrastuzumabColorectal cancerOncologyLapatinibInternal medicineKRASEpidermal growth factor receptorPertuzumabBiomarkerMetastatic breast cancerCancerBreast cancerBiologyBiochemistryColorectal Cancer Treatments and StudiesHER2/EGFR in Cancer ResearchGastric Cancer Management and Outcomes